No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Inebilizumab Improves Outcomes in Generalized Myasthenia Gravis

byAstrid BradshawandAlisha Yi

April 23, 2025

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Inebilizumab Improves Outcomes in Generalized Myasthenia Gravis

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy

Association between atrial fibrillation and both the in-hospital mortality and disease severity in acute pancreatitis: insights from a multicenter study

Inebilizumab improves outcome in patients generalized myasthenia gravis

Ultrasound-guided radiofrequency ablation may be effective for treatment of aldosterone-producing adenomas

RelatedReports

Imaging and Intervention

Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy

January 15, 2026

Mild-to-moderate hypertriglyceridemia associated with higher risk of acute pancreatitis

Cardiology

Association between atrial fibrillation and both the in-hospital mortality and disease severity in acute pancreatitis: insights from a multicenter study

January 12, 2026

Age and number of islet autoantibodies associated with diabetes risk

Neurology

Inebilizumab improves outcome in patients generalized myasthenia gravis

July 10, 2025

Chronic Disease

Inebilizumab reduces the risk of flares in IgG4-related disease

April 8, 2025

Levodopa for Parkinson’s disease more effective than newer generation therapies

Exenatide does not slow Parkinson’s disease progression compared to placebo

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Upper extremity pain associated with poor functional recovery post-stroke

Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study

Critical-care pain observation tool demonstrates reliability for critically ill pediatric patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Inebilizumab Improves Outcomes in Generalized Myasthenia Gravis

Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy

Association between atrial fibrillation and both the in-hospital mortality and disease severity in acute pancreatitis: insights from a multicenter study

Inebilizumab improves outcome in patients generalized myasthenia gravis

Ultrasound-guided radiofrequency ablation may be effective for treatment of aldosterone-producing adenomas

Exenatide does not slow Parkinson’s disease progression compared to placebo

RelatedReports

Edaravone dexborneol improves functional independence in patients with acute ischaemic stroke following endovascular thrombectomy

Association between atrial fibrillation and both the in-hospital mortality and disease severity in acute pancreatitis: insights from a multicenter study

Inebilizumab improves outcome in patients generalized myasthenia gravis

Inebilizumab reduces the risk of flares in IgG4-related disease

Exenatide does not slow Parkinson’s disease progression compared to placebo

Upper extremity pain associated with poor functional recovery post-stroke

Critical-care pain observation tool demonstrates reliability for critically ill pediatric patients

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits